Dignity in the Final Chapters: Maharashtra Mandates Medical Boards for End-of-Life Decisions in Private Hospitals

MUMBAI — In a major regulatory shift aimed at balancing patient autonomy with clinical oversight, the Maharashtra state government has issued a comprehensive framework requiring all private hospitals to establish specialized medical boards to oversee end-of-life decisions. The government resolution, enacted on July 17, 2026, extends a standardized protocol for the withdrawal or withholding of life-sustaining treatment—commonly referred to as passive euthanasia—to private healthcare facilities, which care for a significant portion of the state’s terminally ill population.

This administrative directive bridges a critical operational gap, operationalizing safeguards established by the Supreme Court of India. By enforcing a multi-tiered medical review process, the state seeks to streamline the execution of living wills while mitigating the risk of coercion, legal vulnerability for clinicians, and premature treatment termination.

A Two-Step Safeguard for Critical Decisions

Under the new government resolution, private hospitals must implement a rigid, two-step evaluation structure before any life-sustaining interventions can be legally withdrawn.

1. The Primary Medical Board: Formed at the institutional level, this board must be led by the hospital administration. It must include the patient’s primary treating physician, a critical care specialist, and a senior physician or surgeon. This group evaluates the clinical status of the individual to determine if further treatment yields any therapeutic benefit.

2. The Secondary Medical Board: If the primary board recommends the withdrawal of life support, the case undergoes a mandatory secondary review. In Mumbai and Mumbai Suburban districts, this review involves the medical superintendent of the state-run JJ Hospital. Outside these metropolitan zones, the framework mandates district-level oversight led by district civil surgeons, who are tasked with maintaining panels of independent, registered doctors to act as external experts.

This dual-layer structure is explicitly designed to ensure that end-of-life choices rest on rigorous collective medical judgment rather than the isolated decision of a single practitioner or immediate pressure from distressed family members.

Aligning State Realities with Supreme Court Precedents

The state’s intervention directly follows the Supreme Court of India’s March 11, 2026, ruling in the Harish Rana v. Union of India case. That judgment clarified the legal boundaries for withdrawing life support under the broader umbrella of passive euthanasia and advance directives. The Rana ruling built upon the historic 2018 Common Cause judgment, which first legally recognized an individual’s right to die with dignity and validated the use of living wills under strict institutional checks.

Notably, the 2026 Supreme Court ruling explicitly recognized clinically assisted nutrition and hydration as forms of medical treatment rather than basic care, meaning they can be legally withdrawn under appropriate, terminal circumstances. While Maharashtra had established similar medical boards within government hospitals in 2024, the July 2026 order brings the vast private healthcare sector into alignment, ensuring standard practice across both public and private systems.

Defining Passive Euthanasia: What It Is and What It Is Not

For health-conscious consumers and families navigating these emotional crises, understanding the terminology is vital. Medical authorities emphasize that passive euthanasia is fundamentally distinct from active euthanasia.

• Passive Euthanasia: The withholding or withdrawal of medical interventions (such as mechanical ventilators, dialysis, or artificial nutrition) that merely prolong the biological process of dying without offering a meaningful recovery. The underlying terminal illness is allowed to take its natural course.

• Active Euthanasia: The deliberate administration of a lethal agent to end a patient’s life, an act that remains strictly illegal and punishable under Indian criminal law.

The ethical and legal focus of the new framework rests on respecting patient autonomy—allowing individuals to decide what happens to their bodies through advance care planning—while avoiding the prolonged, unnecessary suffering caused by futile medical interventions.

The Broader Public Health Context: Palliative Care Deficits

While the regulatory framework addresses legal vulnerabilities, public health experts note that procedural consistency is only one part of high-quality end-of-life care. Data from the World Health Organization (WHO) indicates that approximately 56.8 million people globally require palliative care annually, yet only about 14% actually receive it.

In India, this gap frequently translates into severe emotional and catastrophic financial distress for families, who often pay out-of-pocket for prolonged, ineffective intensive care treatments. Public health advocates emphasize that while structured hospital boards bring legal clarity, they do not replace the fundamental need for early palliative care, robust pain management, and transparent communication between medical teams and families.

The Clinical Perspective: “Withdrawing Treatment Is Not Withdrawing Care”

Medical ethics organizations, including the American Medical Association (AMA), consistently reinforce that when life-sustaining treatment is stopped, the clinician’s duty to the patient does not end. Instead, the focus transitions from curative care to aggressive symptom control, comfort, and psychological support.

Prominent bioethicists emphasize that the primary role of a physician in these scenarios is to help patients and their designated surrogates identify core values and treatment preferences long before a crisis occurs. In terminal care, the essential clinical question shifts from “What can we do?” to “Does this specific treatment align with the patient’s defined goals, or does it merely prolong the process of dying?”

Implementation Challenges and Systemic Limitations

Despite the robust design of Maharashtra’s framework, healthcare delivery experts warn of potential hurdles in the real world:

• Administrative Delays: The requirement for secondary reviews involving district civil surgeons or government hospital superintendents could introduce bureaucratic delays in time-sensitive medical situations.

• Varying Institutional Expertise: Smaller private hospitals may struggle to quickly assemble qualified, senior critical care specialists to populate primary boards.

• Health Literacy Barriers: Families facing high-stress medical crises frequently struggle to comprehend complex legal concepts like “advance directives” or distinguishing between clinical interventions and basic comfort care.

Medical law experts advise that the safest path forward requires continuous training for hospital staff, clear institutional consent templates, and the immediate integration of supportive palliative care teams the moment an end-of-life review is initiated.

What This Means for Patients, Families, and Clinicians

For the general public, Maharashtra’s directive serves as a crucial reminder of the importance of advance care planning. Documenting preferences through a legally valid living will or appointing a trusted healthcare proxy ensures that an individual’s wishes are respected if they lose the capacity to make decisions due to illness or trauma. However, these documents are only effective if discussed openly with family members and primary physicians beforehand.

For healthcare professionals, the framework highlights the expanding role of medical ethics committees, palliative medicine, and structured communication strategies within the private sector. Ultimately, the state’s new mandate underscores a growing societal consensus: quality healthcare must encompass not only the preservation of life, but also the protection of dignity and comfort at its end.

Medical Disclaimer

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

Legal & Government Sources

• Maharashtra Government Resolution: Department of Public Health, Framework on End-of-Life Decision Boards in Private Healthcare Facilities, issued July 17, 2026.